热门资讯> 正文
Tenax Therapeutics任命Thomas Staab为首席财务官
2026-04-22 19:38
- Tenax Therapeutics (TENX) has appointed Thomas Staab as chief financial officer, effective May 11, 2026, replacing Thomas McGauley.
- Staab brings over 25 years of leadership experience across management and corporate finance roles in the healthcare industry, the company said. He most recently served as CFO and Secretary of LENSAR until May 2026 and Senior Vice President, CFO, and Treasurer at BioCryst Pharmaceuticals from July 2011 to February 2020.
- TENX +0.88% premarket to $13.8.
- Source: Press Release
More on Tenax Therapeutics
- Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
- Tenax Therapeutics: Some Future Potential
- Tenax wins bullish view at Cantor ahead of pivotal readout
- Seeking Alpha’s Quant Rating on Tenax Therapeutics
- Historical earnings data for Tenax Therapeutics
推荐文章
华盛早报 | SpaceX、OpenAI齐申请上市；英伟达财报强劲并回购800亿美元；美联储会议纪要多数官员放鹰
最火“AI交易”涨势暂歇！存储、光通信回调后如何上车更稳妥？这2个ETF+3张期权值得重点关注
世界杯投资指南 | 别光看球！这份2026世界杯概念股最全名单，基建、酒店、旅游都在内，赶紧收藏
美股机会日报 | 芯片股盘前集体反攻！英特尔涨超5%；段永平Q1豪掷12亿美元建仓特斯拉；英伟达将于盘后放榜
英伟达期权链暗示财报后股价大幅波动？市场押注3500亿美元市值巨震！
新股申购 | “3D打印公司”创想三维今起招股！一手入场费2848.44港元
华盛早报 | 特朗普称将很快结束对伊战争！30年美债收益率升至近20年来最高水平；英伟达今日盘后放榜
5月20日外盘头条：特朗普再发威胁 谷歌升级搜索 大幅下调订阅价格 北约开始考虑护航船霍尔木兹海峡
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
